Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-24

Clinical Trial Update: A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis [Phase 3]

View source ↗

Summary

Phase 3 study comparing two combination vaginal/ovular therapies for secondary vulvar/vaginal symptoms of infectious vaginitis and vaginosis; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metronidazole + Nystatin + Fluocinolone ovule (Metronidazole; Nystatin; Fluocinolone)
  • Terconazole + Clindamycin + Fluocinolone ovule (Terconazole; Clindamycin; Fluocinolone)

Snippet

Sponsor: Janssen-Cilag, S.A. | Conditions: Vaginitis, Infectious Vaginosis | Phase 3 | Status: COMPLETED | Results posted: 2013-12-24